Kaneka Advances Ubiquinol Quality with New Testing Phase
PASADENA, Texas, July 15, 2026 Kaneka Nutrients has announced the third phase of its independent Ubiquinol authenticity testing program,...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PASADENA, Texas, July 15, 2026 Kaneka Nutrients has announced the third phase of its independent Ubiquinol authenticity testing program,...
PONTE VEDRA, Fla., July 15, 2026 Orasis Pharmaceuticals has reached an important international regulatory milestone with the submission of...
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
SAN DIEGO, June 7, 2026 LENZ Therapeutics announced that Everest Medicines has acquired the rights to develop, manufacture, and...
Rockville, Maryland, U.S. | April 15, 2026 Leadiant Biosciences has announced a major regulatory milestone with Health Canada approval...
